From: Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
p value | Odds ratio (95% CI) | |
---|---|---|
Cerebral metastasis | 0.48 | 3.18 (0.12–81.69) |
Pleural effusion | 0.66 | 0.53 (0.33–8.71) |
ECOG PS | 0.39 | 2.58 (0.92–22.75) |
Serum kyn/trp | 0.01 | 0.01 (0.00–0.41) |
Serum quinolic acid | 0.81 | 1.38 (0.09–20.30) |